Zdrowie i gospodarka · 12/12/2018
FDA Releases Final Guidance on Biosimilars and BPCI Act
The FDA has released a final guidance document to inform prospective applicants and clarify FDA's interpretation of statutory requirements related to biosimilar development and the Biologics Price Competition and Innovation Act of 2009.
Source: Federal Register — Food and Drug AdministrationOpen original release →